Lascco
Company Team Projects Media Contact

 

Investing in biomedical discoveries

LASCCO SA is a biomedical-technology development private company based in Geneva, Switzerland. The primary objective of LASCCO is to bring promising early-stage biomedical technologies – therapeutics and diagnostics – developed in research institutes to the attention of the pharmaceutical industry.

 

 

LATEST NEWS:

Combioxin SA escalates to high dose in CAL02-001 trial in patients with severe pneumococcal pneumonia following IDMC's positive recommendation- 09/08/2016

Lascco